Effects on bone mineral density of 12-month goserelin treatment in over 40-year-old women with uterine myomas
- 1 July 1995
- journal article
- other
- Published by Springer Nature in Calcified Tissue International
- Vol. 57 (1) , 78-80
- https://doi.org/10.1007/bf00299002
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.Journal of Clinical Endocrinology & Metabolism, 1993
- Impact of medical treatment of endometriosis on bone massAmerican Journal of Obstetrics and Gynecology, 1993
- 2 Current techniques for bone mass measurementBailliere's Clinical Obstetrics and Gynaecology, 1991
- Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term follow-upEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1991
- Sequential Gn‐RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomataInternational Journal of Gynecology & Obstetrics, 1990
- Use of Goserelin Depot, A Gonadotropin‐Releasing Hormone Agonist, for the Treatment of Menorrhagia and Severe Anemia in Women with Leiomyomata UteriActa Obstetricia et Gynecologica Scandinavica, 1990
- Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-upFertility and Sterility, 1989
- Determinants of bone density in normal women: risk factors for future osteoporosis?BMJ, 1989
- Long‐term follow‐up of patients with uterine fibroids after treatment with the LHRH agonist buserelinBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteriFertility and Sterility, 1988